211 related articles for article (PubMed ID: 3509782)
1. The influence of 1 alpha,25- and 24(R),25-dihydroxyvitamin D3 on bone constituents during early mineralization in the rat.
Vukicević S; Bagi C; Vujicić G; Krempien B; Stavljenić A; Herak M
Bone Miner; 1986 Oct; 1(5):383-96. PubMed ID: 3509782
[TBL] [Abstract][Full Text] [Related]
2. 1a,25-Dihydroxyvitamin D3 stimulates alkaline phosphatase activity and inhibits soft-tissue proliferation in implants of bone matrix.
Vukicević S; Stavljenić A; Bagi C; Vujicić G; Kracun I; Winter I
Clin Orthop Relat Res; 1985 Jun; (196):285-91. PubMed ID: 3873307
[TBL] [Abstract][Full Text] [Related]
3. Effects of 1 alpha,25- and 24R,25-dihydroxyvitamin D3 on aluminum-induced rickets in growing uremic rats.
Vukicević S; Krempien B; Stavljenić A
J Bone Miner Res; 1987 Dec; 2(6):533-45. PubMed ID: 3502683
[TBL] [Abstract][Full Text] [Related]
4. [Comparative study of the effect of 1,25 dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 on calcium homeostasis and bone tissue state in rats during hypokinesia].
Sergeev IN; Blazheevich NV; Kaplanskiĭ AS; Shvets VN; Belakovskiĭ MS
Vopr Med Khim; 1987; 33(1):100-7. PubMed ID: 3495067
[TBL] [Abstract][Full Text] [Related]
5. [Effect of vitamin D3 and its metabolites 1,25-dihydroxycholecalciferol and 24,25-dihydroxycholecalciferol on callus mineralization in rats with femoral fracture].
Blazhevich NV; Sergeev IN; Arkhapchev IuP; Isaeva VA; Spirichev VB
Vopr Med Khim; 1982; 28(6):98-105. PubMed ID: 6297167
[TBL] [Abstract][Full Text] [Related]
6. [Comparative study of the effects of alpha-25-dihydroxycholecalciferol and 24, 25-dihydroxycholecalciferol on calcium-phosphorus metabolism and on bone tissue in experimental kidney insufficiency in rats].
Alekseeva AI; Spirichev VB; Bogoslovskiĭ NA; Kisel'nikova TA
Vopr Med Khim; 1983; 29(5):103-12. PubMed ID: 6606264
[TBL] [Abstract][Full Text] [Related]
7. Effect of vitamin D metabolites on the expression of alkaline phosphatase activity by epiphyseal hypertrophic chondrocytes in primary cell culture.
Hale LV; Kemick ML; Wuthier RE
J Bone Miner Res; 1986 Dec; 1(6):489-95. PubMed ID: 3509742
[TBL] [Abstract][Full Text] [Related]
8. [Effect of 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 on growth and remodeling of rat bones during hypokinesia (histomorphometric study)].
Kabitskaia OE; Savik ZF; Kaplanskiĭ AS; Shvets VN; Sergeev IN
Kosm Biol Aviakosm Med; 1984; 18(4):49-55. PubMed ID: 6332944
[TBL] [Abstract][Full Text] [Related]
9. Effect of 1,25(OH)2D3 and 24,25(OH)2D3 on experimental rickets.
Kraft D; Offermann G; Steldinger R; Gawlik D
Res Commun Chem Pathol Pharmacol; 1979 Dec; 26(3):571-80. PubMed ID: 523788
[TBL] [Abstract][Full Text] [Related]
10. Activity of ornithine decarboxylase and creatine kinase in soft and hard tissue of vitamin D-deficient chicks following parenteral application of 1,25-dihydroxyvitamin D3 or 24R,25-dihydroxyvitamin D3.
Ittel TH; Ross FP; Norman AW
J Bone Miner Res; 1986 Feb; 1(1):23-31. PubMed ID: 3509739
[TBL] [Abstract][Full Text] [Related]
11. EHDP-induced rachitic syndrome in rats is not reversed by vitamin D metabolites.
Atkin I; Ornoy A; Pita JC; Muniz OE; Agundez A; Castiglione G; Howell DS
Anat Rec; 1988 Jan; 220(1):22-30. PubMed ID: 3126678
[TBL] [Abstract][Full Text] [Related]
12. The vitamin D hormone and its nuclear receptor: molecular actions and disease states.
Haussler MR; Haussler CA; Jurutka PW; Thompson PD; Hsieh JC; Remus LS; Selznick SH; Whitfield GK
J Endocrinol; 1997 Sep; 154 Suppl():S57-73. PubMed ID: 9379138
[TBL] [Abstract][Full Text] [Related]
13. [Effect of 1,25-dihydroxycholecalciferol and 24,25-dihydroxycholecalciferol on calcium homeostasis in rats treated with hydrocortisone].
Karatabanova NA; Sokolova SV; Bogoslovskiĭ NA; Spirichev VB
Vopr Med Khim; 1985; 31(3):112-6. PubMed ID: 3875180
[TBL] [Abstract][Full Text] [Related]
14. Light- and electron-microscopic evaluation of the effects of 1,25-dihydroxyvitamin D3 on bone of thyroparathyroidectomized rats.
Weisbrode SE; Capen CC; Norman AW
Am J Pathol; 1979 Nov; 97(2):247-60. PubMed ID: 525673
[TBL] [Abstract][Full Text] [Related]
15. Response of rachitic rat bones to 1,25-dihydroxyvitamin D3: biphasic effects on mineralization and lack of effect on bone resorption.
Gallagher JA; Beneton M; Harvey L; Lawson DE
Endocrinology; 1986 Oct; 119(4):1603-9. PubMed ID: 3757903
[TBL] [Abstract][Full Text] [Related]
16. Influence of vitamin D3 metabolites on the production of interleukins 1,2 and 3.
Hodler B; Evêquoz V; Trechsel U; Fleisch H; Stadler B
Immunobiology; 1985 Nov; 170(4):256-69. PubMed ID: 3002965
[TBL] [Abstract][Full Text] [Related]
17. A direct effect of 24,25-(OH)2D3 and 1,25-(OH)2D3 on the modeling of fetal mice long bones in vitro.
Schwartz Z; Soskolne WA; Atkin I; Goldstein M; Ornoy A
J Bone Miner Res; 1989 Apr; 4(2):157-63. PubMed ID: 2786320
[TBL] [Abstract][Full Text] [Related]
18. The effect of vitamin D on bone in vivo.
Tam CS; Heersche JN; Jones G; Murray TM; Rasmussen H
Endocrinology; 1986 Jun; 118(6):2217-24. PubMed ID: 3486118
[TBL] [Abstract][Full Text] [Related]
19. [Comparative evaluation of biological activity of 1 alpha,25-dihydroxycholecalciferol and 24,25-dihydroxycholecalciferol in rats].
Alekseeva IA; Spiricheva VB; Blazhevich NV; Sokolova SV; Pereverzeva OG
Vopr Med Khim; 1982; 28(5):71-8. PubMed ID: 6983777
[TBL] [Abstract][Full Text] [Related]
20. Regulation of alkaline phosphatase by 1,25-dihydroxyvitamin D3 and ascorbic acid in bone-derived cells.
Franceschi RT; Young J
J Bone Miner Res; 1990 Nov; 5(11):1157-67. PubMed ID: 1702922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
